Prosonix provide cGMP & ATEX sonocrystallization Prosonitron™ ultrasonic process and reactor technology for the manufacture of highly engineered crystalline pharmaceutcial products. They are aligned with emergent FDA “QbD” and “Design for Intent” philosophy. The proprietary systems are of modular design for optimum flexibility and are an easy retro-fit to existing pharmaceutical manufacturing equipment. They are proven across scale in API production and can be seen as sustainable green technology for bulk API production.